Skip to main content

Advertisement

Open Peer Review Reports for: Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
26 Sep 2018 Submitted Original manuscript
22 Oct 2018 Reviewed Reviewer Report - Shabbir Alibhai
10 Feb 2019 Reviewed Reviewer Report - Martin Boegemann
12 Mar 2019 Author responded Author comments - Joshua Philip Schiff
Resubmission - Version 2
12 Mar 2019 Submitted Manuscript version 2
14 Apr 2019 Author responded Author comments - Joshua Philip Schiff
Resubmission - Version 3
14 Apr 2019 Submitted Manuscript version 3
8 May 2019 Author responded Author comments - Joshua Philip Schiff
Resubmission - Version 4
8 May 2019 Submitted Manuscript version 4
13 May 2019 Author responded Author comments - Joshua Philip Schiff
Resubmission - Version 5
13 May 2019 Submitted Manuscript version 5
Publishing
17 May 2019 Editorially accepted
31 May 2019 Article published 10.1186/s12885-019-5729-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement